The intracellular signaling network triggered by binding of growth factors and cytokines to cellular surface receptors is rigorously regulated in cells and often involves recruitment of adapter molecules to transmembrane receptors (1, 2). Downstream of kinase (Dok) 1 proteins are a recently discovered family of adapter molecules (including Dok-1, -2, and -3), which have emerged as an expanding group of insulin receptor substrates (IRSs)-related signaling molecules, consisting of an NH 2 -terminal tandem of PH and PTB domains. The previously identified Dok members, p62 Dok (Dok-1), Dok-2 (Dok-R), and Dok-3, are predominantly expressed in hematopoietic cells (3). Although these three Doks have similar domains to IRSs, they can be distinguished from the IRS family based on sequence homology and functional interactions. Hematopoietic Dok molecules are prominent substrates of the Src and Abl tyrosine kinases. Upon tyrosine phosphorylation, they acquire the ability to bind SH2 domain-containing molecules such as RasGAP, Csk,. More recently, Grimm et al. (6) identified two novel Dok-like molecules, Dok-4 and Dok-5, as partners and substrates for the receptor tyrosine kinase Ret. Whereas Dok-5 appears concentrated in the central nervous system, Dok-4 seems most highly expressed in epithelial and endothelial cells (4, 6). We have reported (4) that a significant proportion of Dok-4 is constitutively associated with the cell membrane and that it can serve as a substrate for tyrosine kinases of the Src family. However, because Dok-4 lacks consensus binding sites for known SH2 domains, its exact function has been difficult to define. We found that Dok-4 inhibited activation of the Erk substrate Elk-1 by Ret and by the Src kinase Fyn in epithelial cells. On the other hand, by using different approaches and cellular systems, Grimm et al. (6) and Cai et al.